Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
split virion influenza vaccine (2 trials)
aluminum hydroxide (Gaviscon) (1 trial)
streptococcus pyogenes (1 trial)
streptococcus pyogenes vaccine (1 trial)
Influenza, Human (Phase 3)
Rheumatic Fever (Phase 1)
Trials (3 total)
Trial APIs (4 total)